Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus

In this trial involving patients with diabetes without evidence of cardiovascular disease, the risk of serious vascular events was similar in those who received n−3 fatty acid supplements and those who received placebo.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2018-10, Vol.379 (16), p.1540-1550
Hauptverfasser:	Bowman, Louise, Mafham, Marion, Wallendszus, Karl, Stevens, Will, Buck, Georgina, Barton, Jill, Murphy, Kevin, Aung, Theingi, Haynes, Richard, Cox, Jolyon, Murawska, Aleksandra, Young, Allen, Lay, Michael, Chen, Fang, Sammons, Emily, Waters, Emma, Adler, Amanda, Bodansky, Jonathan, Farmer, Andrew, McPherson, Roger, Neil, Andrew, Simpson, David, Peto, Richard, Baigent, Colin, Collins, Rory, Parish, Sarah, Armitage, Jane
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Arteriosclerosis Aspirin Aspirin - therapeutic use Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - etiology Cardiovascular Diseases - mortality Cardiovascular Diseases - prevention & control Cerebral infarction Clinical trials Councils Data analysis Diabetes Diabetes Complications - prevention & control Diabetes mellitus Diabetes Mellitus - drug therapy Diabetes Mellitus - mortality Dietary Supplements Disease prevention Fatty acids Fatty Acids, Omega-3 - adverse effects Fatty Acids, Omega-3 - therapeutic use Female Follow-Up Studies Grants Heart Hemorrhage Humans Information sharing Ischemia Kaplan-Meier Estimate Male Medical research Middle Aged Myocardial infarction Olive oil Omega-3 fatty acids Platelet Aggregation Inhibitors - therapeutic use Population Questionnaires Supplements Systematic review Transient ischemic attack Treatment Outcome Writing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In this trial involving patients with diabetes without evidence of cardiovascular disease, the risk of serious vascular events was similar in those who received n−3 fatty acid supplements and those who received placebo.
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJMoa1804989